Business Wire reports that Overlake Medical Center became the first hospital in Washington state to use the Cochlear Nucleus Profile With Slim Straight (CI522) platform last month, when Dr. Trac Duong, M.D., used it on a patient suffering from severe hearing loss. Cochlear implant surgery can allow people with moderate to profound loss to hear again.
Cochlear Nucleus Profile Series platform is the world’s thinnest cochlear implant available today and was just recently approved by the Food and Drug Administration. The thin design reduces the implant outline to maximize discretion. The benefit of having an implant with an unnoticeable appearance is an important factor for candidates receiving the surgery. This allows each patient to live full and active lives without any attention brought to the implant once it is in place; they are able to fully reconnect with family, friends and their community.
Overlake Medical Center serves the Eastside Seattle community and is known for being at the forefront of innovation when it comes to medical technology. As the first hospital in the state to utilize this technology and the only hospital on the Eastside to perform this surgery, Overlake is proud to provide the hearing impaired with this opportunity that can allow them to have a better, fuller life.